U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Acquired by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. grew its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH) by 5.6% during the 1st quarter, HoldingsChannel.com reports. The firm owned 316,489 shares of the company’s stock after buying an additional 16,698 shares during the period. Envestnet Asset Management Inc.’s holdings in U.S. Physical Therapy were worth $22,901,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Principal Financial Group Inc. increased its holdings in U.S. Physical Therapy by 2.3% during the 1st quarter. Principal Financial Group Inc. now owns 84,964 shares of the company’s stock worth $6,148,000 after purchasing an additional 1,873 shares during the period. Teacher Retirement System of Texas boosted its position in shares of U.S. Physical Therapy by 6.9% in the 1st quarter. Teacher Retirement System of Texas now owns 57,381 shares of the company’s stock valued at $4,152,000 after purchasing an additional 3,710 shares during the period. First Horizon Advisors Inc. boosted its position in shares of U.S. Physical Therapy by 35.0% in the 1st quarter. First Horizon Advisors Inc. now owns 1,929 shares of the company’s stock valued at $140,000 after purchasing an additional 500 shares during the period. Bessemer Group Inc. boosted its position in shares of U.S. Physical Therapy by 4.4% in the 1st quarter. Bessemer Group Inc. now owns 4,929 shares of the company’s stock valued at $357,000 after purchasing an additional 208 shares during the period. Finally, Oppenheimer Asset Management Inc. lifted its position in U.S. Physical Therapy by 15.7% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 25,588 shares of the company’s stock worth $1,852,000 after acquiring an additional 3,464 shares during the period.

U.S. Physical Therapy Stock Performance

Shares of NYSE USPH opened at $73.12 on Wednesday. The stock has a fifty day moving average price of $76.69 and a two-hundred day moving average price of $78.76. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.17 and a current ratio of 1.17. The firm has a market cap of $1.11 billion, a P/E ratio of 33.54, a PEG ratio of 3.58 and a beta of 1.44. U.S. Physical Therapy, Inc. has a 1 year low of $62.77 and a 1 year high of $101.20.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, beating analysts’ consensus estimates of $0.46 by $0.02. U.S. Physical Therapy had a return on equity of 7.89% and a net margin of 4.57%. The business had revenue of $183.79 million for the quarter, compared to the consensus estimate of $176.78 million. During the same quarter in the previous year, the company posted $0.51 earnings per share. U.S. Physical Therapy’s revenue for the quarter was up 18.0% compared to the same quarter last year. Research analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 13th. Stockholders of record on Friday, May 23rd were issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.46%. The ex-dividend date was Friday, May 23rd. U.S. Physical Therapy’s dividend payout ratio is 82.57%.

Insider Transactions at U.S. Physical Therapy

In other news, Director Nancy Ham sold 400 shares of U.S. Physical Therapy stock in a transaction that occurred on Thursday, June 12th. The stock was sold at an average price of $78.01, for a total transaction of $31,204.00. Following the sale, the director owned 2,594 shares of the company’s stock, valued at approximately $202,357.94. This trade represents a 13.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.00% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the company. Barrington Research reissued an “outperform” rating and set a $98.00 target price on shares of U.S. Physical Therapy in a research note on Tuesday, July 1st. JPMorgan Chase & Co. lowered their price target on U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating for the company in a research report on Wednesday, March 19th. JMP Securities restated a “market outperform” rating and set a $113.00 price objective on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. Finally, Wall Street Zen upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Thursday, May 8th. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, U.S. Physical Therapy currently has an average rating of “Moderate Buy” and a consensus price target of $109.00.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.